Felodipine in addition to beta-adrenergic blockade for angina pectoris. a multicentre, randomized, placebo-controlled trial.

Author: OstergaardO, RønnevikP K, SilkeB

Paper Details 
Original Abstract of the Article :
The additional efficacy, duration of action and tolerability of felodipine were evaluated in patients with stable angina pectoris and a positive stress test who were already receiving therapy with a beta-adrenergic blocker. One hundred and twenty-eight patients were randomized to double-blind treatm...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1093/oxfordjournals.eurheartj.a060774

データ提供:米国国立医学図書館(NLM)

Felodipine: Adding a New Layer to Angina Treatment

The world of [cardiology] is constantly evolving, with new therapies emerging to address the challenges of [angina pectoris]. This study explores the efficacy and safety of [felodipine] in patients already receiving [beta-adrenergic blockade] for angina. Think of it as adding a new layer of protection to an already existing shield, providing enhanced defense against the discomfort of angina. The researchers conducted a rigorous [multicenter, randomized, placebo-controlled trial], testing the effects of felodipine on exercise tolerance and other important clinical parameters. The results offer valuable insights into the potential benefits of felodipine as an adjunctive therapy for angina.

Felodipine: A Beacon in the Desert of Angina

The study found that [felodipine] significantly [increased exercise duration] in patients with angina, even those already receiving beta-blocker therapy. This suggests that felodipine can offer additional benefit in managing angina symptoms. The researchers observed [no significant changes in exercise test parameters 24 hours after medication], indicating that the effects of felodipine are sustained for a significant period. This finding is particularly encouraging, as it suggests that felodipine can provide a more consistent level of relief from angina symptoms.

Finding Relief in the Desert of Angina: A Journey Towards Wellness

The study’s findings offer hope for those struggling with angina. Felodipine, when added to existing beta-blocker therapy, can provide additional relief from symptoms and improve overall well-being. This means that individuals can enjoy a better quality of life, with less discomfort and more energy to navigate their daily routines. The study also highlights the importance of [individualized treatment], as the effectiveness of felodipine may vary from person to person. It is essential to work with a healthcare professional to determine the best treatment plan for your specific needs.

Dr. Camel's Conclusion

This study demonstrates the potential of felodipine as an adjunctive therapy for angina. By providing additional relief from symptoms and improving exercise tolerance, felodipine can help individuals manage their condition and enjoy a better quality of life. The findings underscore the importance of individualized treatment approaches to ensure optimal outcomes for those navigating the desert of angina.

Date :
  1. Date Completed 1996-12-17
  2. Date Revised 2019-05-12
Further Info :

Pubmed ID

8881845

DOI: Digital Object Identifier

10.1093/oxfordjournals.eurheartj.a060774

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.